title: Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption.
abstract: Inosine monophosphate dehydrogenase (IMPDH) is a pivotal enzyme in the de novo pathway of guanine nucleotide biosynthesis. Inhibitors of this enzyme decrease intracellular guanine nucleotide levels by 50-80% and have potential as anti-neoplastic agents. Both mycophenolic acid (MPA) and AVN-944 are highly specific inhibitors of IMPDH that cause cell cycle arrest or apoptosis in lymphocytes and leukemic cell lines. We have examined the mechanisms by which these two agents cause cytotoxicity. Both MPA and AVN-944 inhibit the growth of K562 cells, and induce apoptosis in Raji B and CCRF-CEM T cells. Both compounds strikingly inhibit RNA synthesis within 2 h of exposure. Depletion of guanine nucleotides by MPA and AVN-944 also causes an early and near-complete reduction in levels of the 45S precursor rRNA synthesis and the concomitant translocation of nucleolar proteins including nucleolin, nucleophosmin, and nucleostemin from the nucleolus to the nucleoplasm. This efflux correlates temporally with the sustained induction of p53 in cell lines with wild-type p53. We conclude that inhibition of IMPDH causes a primary reduction in rRNA synthesis and secondary nucleolar disruption and efflux of nucleolar proteins that most likely mediate cell cycle arrest or apoptosis. The ability of AVN-944 to induce apoptosis in a number of leukemic cell lines supports its potential utility in the treatment of hematologic malignancies.
authors.affiliation: Department of Medicine, Division of Oncology, Stanford University, Stanford, CA 94305-5796, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Huang
authors.forename: Yanshan
authors.initials: Y
authors.lastname: Ji
authors.forename: Koji
authors.initials: K
authors.lastname: Itahana
authors.forename: Yanping
authors.initials: Y
authors.lastname: Zhang
authors.forename: Beverly
authors.initials: B
authors.lastname: Mitchell
mesh_terms: D000818:Animals; D002219:Carbamates / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002466:Cell Nucleolus / Q000378:metabolism*; D049109:Cell Proliferation; D002470:Cell Survival / Q000187:drug effects; D005786:Gene Expression Regulation; D016158:Genes, p53; D006150:Guanine Nucleotides / Q000378:metabolism*; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors*; D020014:K562 Cells; D051379:Mice; D009173:Mycophenolic Acid / Q000494:pharmacology*; D010671:Phenylurea Compounds / Q000494:pharmacology*; D012322:RNA Precursors / Q000096:biosynthesis*; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D002219:Carbamates; D006150:Guanine Nucleotides; D010671:Phenylurea Compounds; D012322:RNA Precursors; D012335:RNA, Ribosomal; D007168:IMP Dehydrogenase; D009173:Mycophenolic Acid; C526922:AVN 944